R. Mouzo

A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D—a randomised multicentre international clinical trial

J. Cunningham, J. Cannata-Andía, M. Naves-Díaz, 2022, BMC Medicine.

Continuous Intravenous Sodium Ferric Gluconate Improves Efficacy in the Maintenance Phase of EPOrHu Administration in Hemodialysis Patients

J. Varela, T. G. Falcón, R. Mouzo, 2002, American Journal of Nephrology.

Treatment of aluminium intoxication: a new scheme for desferrioxamine administration.

W. Douthat, J. Cannata Andía, R. Mouzo, 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Management of neuroendocrine tumor in a patient with Rubinstein-Taybi syndrome in chronic hemodialysis

F. Simal, R. Mouzo, I. Romaniouk, 2018, Nefrología (English Edition).